Inhibitory effects of quinolone antibacterial agents on eucaryotic topoisomerases and related test systems.
作者信息
Gootz T D, Barrett J F, Sutcliffe J A
机构信息
Department of Immunology and Infectious Diseases, Pfizer Central Research, Groton, Connecticut 06340.
出版信息
Antimicrob Agents Chemother. 1990 Jan;34(1):8-12. doi: 10.1128/AAC.34.1.8.
Abstract
摘要
相似文献
1
Inhibitory effects of quinolone antibacterial agents on eucaryotic topoisomerases and related test systems.
Antimicrob Agents Chemother. 1990 Jan;34(1):8-12. doi: 10.1128/AAC.34.1.8.
2
Bacterial topoisomerases, anti-topoisomerases, and anti-topoisomerase resistance.
Clin Infect Dis. 1998 Aug;27 Suppl 1:S54-63. doi: 10.1086/514923.
3
Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition.
Antimicrob Agents Chemother. 1994 Nov;38(11):2623-7. doi: 10.1128/AAC.38.11.2623.
4
Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde.
Curr Pharm Des. 2001 Mar;7(5):337-53. doi: 10.2174/1381612013398013.
5
Quinolone uptake by bacteria and bacterial killing.
Rev Infect Dis. 1989 Jul-Aug;11 Suppl 5:S941-6. doi: 10.1093/clinids/11.supplement_5.s941.
6
[Quinolone].
Nihon Rinsho. 2003 Feb;61 Suppl 2:750-5.
7
Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection.
J Antimicrob Chemother. 2003 May;51(5):1109-17. doi: 10.1093/jac/dkg222. Epub 2003 Apr 14.
8
Use of in vitro topoisomerase II assays for studying quinolone antibacterial agents.
Antimicrob Agents Chemother. 1989 Oct;33(10):1697-703. doi: 10.1128/AAC.33.10.1697.
9
The 4-quinolone antibiotics: past, present, and future.
Pharmacotherapy. 1988;8(6):301-14. doi: 10.1002/j.1875-9114.1988.tb04088.x.
10
Exploring DNA topoisomerases as targets of novel therapeutic agents in the treatment of infectious diseases.
Infect Disord Drug Targets. 2007 Mar;7(1):3-9. doi: 10.2174/187152607780090748.
引用本文的文献
1
Intrinsically Antibacterial Carbon Nanoparticles Optimally Entangle into Polymeric Films to Produce Composite Packaging.
ACS Omega. 2024 Oct 29;9(45):45104-45116. doi: 10.1021/acsomega.4c05732. eCollection 2024 Nov 12.
2
Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs.
Front Aging. 2022 Jun 14;3:905261. doi: 10.3389/fragi.2022.905261. eCollection 2022.
3
Interactions Between Intestinal Microbiota and Neural Mitochondria: A New Perspective on Communicating Pathway From Gut to Brain.
Front Microbiol. 2022 Feb 24;13:798917. doi: 10.3389/fmicb.2022.798917. eCollection 2022.
4
Mitochondria and Antibiotics: For Good or for Evil?
Biomolecules. 2021 Jul 17;11(7):1050. doi: 10.3390/biom11071050.
5
Epidemiological Characteristics and Trends of Registered Leprosy Cases in China From 2004 to 2016.
Am J Trop Med Hyg. 2021 Jul 7;105(1):31-36. doi: 10.4269/ajtmh.20-0178.
6
Vitamin D Pretreatment Attenuates Ciprofloxacin-Induced Antibacterial Activity.
Clin Pharmacol. 2020 Oct 12;12:171-176. doi: 10.2147/CPAA.S268330. eCollection 2020.
7
Emerging Therapeutic Targets Against : Update on DNA Repair Response Inhibitors and Genotoxic Drugs.
Front Cell Infect Microbiol. 2020 Jun 12;10:289. doi: 10.3389/fcimb.2020.00289. eCollection 2020.
8
New 7-piperazinylquinolones containing (benzo[d]imidazol-2-yl)methyl moiety as potent antibacterial agents.
Mol Divers. 2018 Nov;22(4):815-825. doi: 10.1007/s11030-018-9834-3. Epub 2018 Jun 7.
9
Possible involvement of ROS generation in vorinostat pretreatment induced enhancement of the antibacterial activity of ciprofloxacin.
Clin Pharmacol. 2017 Oct 17;9:119-124. doi: 10.2147/CPAA.S148448. eCollection 2017.
10
Ciprofloxacin-Induced Antibacterial Activity Is Atteneuated by Pretreatment with Antioxidant Agents.
Pathogens. 2016 Mar 9;5(1):28. doi: 10.3390/pathogens5010028.
本文引用的文献
1
Detection of unscheduled DNA synthesis in hepatocytes isolated from rats treated with genotoxic agents: an in vivo- in vitro assay for potential carcinogens and mutagens.
Carcinogenesis. 1980 Jul;1(7):621-5. doi: 10.1093/carcin/1.7.621.
2
Studies on the mechanism of DNA polymerase alpha. Nascent chain elongation, steady state kinetics, and the initiation phase of DNA synthesis.
J Biol Chem. 1981 Jul 10;256(13):6933-43.
3
Nalidixic acid, oxolinic acid, and novobiocin inhibit yeast glycyl- and leucyl-transfer RNA synthetases.
Science. 1981 Jul 24;213(4506):455-6. doi: 10.1126/science.7017932.
4
Quinolone antibiotics inhibit eucaryotic DNA polymerase alpha and beta, terminal deoxynucleotidyl transferase but not DNA ligase.
Biochem Biophys Res Commun. 1984 Jun 29;121(3):762-9. doi: 10.1016/0006-291x(84)90744-7.
5
Revised methods for the Salmonella mutagenicity test.
Mutat Res. 1983 May;113(3-4):173-215. doi: 10.1016/0165-1161(83)90010-9.
6
The effect of bacterial DNA gyrase inhibitors on DNA synthesis in mammalian mitochondria.
Biochim Biophys Acta. 1983 Sep 9;740(4):417-27. doi: 10.1016/0167-4781(83)90090-8.
7
DNA topoisomerase II from Drosophila melanogaster. Relaxation of supercoiled DNA.
J Biol Chem. 1983 Aug 10;258(15):9536-43.
8
DNA topoisomerases from rat liver: physiological variations.
Nucleic Acids Res. 1983 Feb 25;11(4):1059-75. doi: 10.1093/nar/11.4.1059.
9
A homogeneous type II DNA topoisomerase from HeLa cell nuclei.
J Biol Chem. 1981 Sep 10;256(17):9334-9.
10
ATP-dependent DNA topoisonmerase from D. melanogaster reversibly catenates duplex DNA rings.
Cell. 1980 Aug;21(1):115-25. doi: 10.1016/0092-8674(80)90119-1.
Zotero 插件